Trubar, Inc. (TRBR.V)
1.58
-0.01
(-0.63%)
CAD |
TSXV |
Dec 11, 15:59
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 170.31M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 59.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.902 |
| Price to Book Value | 19.94 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.668 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 97.52% |
Profile
| Trubar, Inc. engages in the sale of hemp-based cannabidiol (CBD) related products. Its product categories include CBD products, plant-based food and beverage, and the global pet care and skin care industries. The company was founded on March 19, 2018 and is headquartered in Toronto, Canada. |
| URL | http://www.simplybetterbrands.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 28, 2026 (est.) |
| Last Earnings Release | Nov. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Trubar, Inc. engages in the sale of hemp-based cannabidiol (CBD) related products. Its product categories include CBD products, plant-based food and beverage, and the global pet care and skin care industries. The company was founded on March 19, 2018 and is headquartered in Toronto, Canada. |
| URL | http://www.simplybetterbrands.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 28, 2026 (est.) |
| Last Earnings Release | Nov. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |